Vikas Sinha insider trades: Verona Pharma (VRNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vikas reports to the SEC
Open-market buys and sales
97 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | VRNA | ↓ Sell | 4,328 | $13.14 | $57K | Direct | Aug 5, 2025 (4d) |
| May 20, 2025 | VRNA | ↓ Sell | 160,000 | $9.39 | $1.5M | Direct | May 22, 2025 (2d) |
| Apr 29, 2025 | VRNA | ↓ Sell | 20,000 | $8.92 | $178K | Direct | May 1, 2025 (2d) |
| Feb 21, 2025 | ALVR | ↓ Sell | 303 | $10.08 | $3K | Direct | Feb 24, 2025 (3d) |
| Jan 23, 2025 | ALVR | ↓ Sell | 129 | $9.50 | $1K | Direct | Jan 27, 2025 (4d) |
| Jan 10, 2025 | ALVR | ↓ Sell | 979 | $0.44 | $431 | Direct | Jan 13, 2025 (3d) |
| Nov 19, 2024 | ALVR | ↓ Sell | 3,186 | $0.55 | $2K | Direct | Nov 20, 2024 (1d) |
| Nov 5, 2024 | ALVR | ↓ Sell | 5,136 | $0.86 | $4K | Direct | Nov 6, 2024 (1d) |
| Oct 22, 2024 | ALVR | ↓ Sell | 3,428 | $0.77 | $3K | Direct | Oct 23, 2024 (1d) |
| Oct 3, 2024 | ALVR | ↓ Sell | 940 | $0.81 | $766 | Direct | Oct 4, 2024 (1d) |
| Aug 19, 2024 | ALVR | ↓ Sell | 3,159 | $0.76 | $2K | Direct | Aug 20, 2024 (1d) |
| Aug 5, 2024 | ALVR | ↓ Sell | 5,251 | $0.73 | $4K | Direct | Aug 7, 2024 (2d) |
| Jul 22, 2024 | ALVR | ↓ Sell | 3,400 | $0.74 | $3K | Direct | Jul 23, 2024 (1d) |
| Jul 2, 2024 | ALVR | ↓ Sell | 939 | $0.72 | $676 | Direct | Jul 3, 2024 (1d) |
| May 17, 2024 | ALVR | ↓ Sell | 3,143 | $0.75 | $2K | Direct | May 21, 2024 (4d) |
| May 3, 2024 | ALVR | ↓ Sell | 4,957 | $0.80 | $4K | Direct | May 7, 2024 (4d) |
| Apr 22, 2024 | ALVR | ↓ Sell | 3,378 | $0.75 | $3K | Direct | Apr 23, 2024 (1d) |
| Apr 2, 2024 | ALVR | ↓ Sell | 885 | $0.77 | $683 | Direct | Apr 4, 2024 (2d) |
| Feb 20, 2024 | ALVR | ↓ Sell | 2,893 | $0.70 | $2K | Direct | Feb 22, 2024 (2d) |
| Feb 5, 2024 | ALVR | ↓ Sell | 18,331 | $0.67 | $12K | Direct | Feb 6, 2024 (1d) |
| Jan 23, 2024 | ALVR | ↓ Sell | 3,205 | $0.67 | $2K | Direct | Jan 25, 2024 (2d) |
| Jan 4, 2024 | ALVR | ↓ Sell | 961 | $0.64 | $614 | Direct | Jan 8, 2024 (4d) |
| Nov 17, 2023 | ALVR | ↓ Sell | 2,490 | $1.63 | $4K | Direct | Nov 21, 2023 (4d) |
| Oct 20, 2023 | ALVR | ↓ Sell | 2,707 | $1.56 | $4K | Direct | Oct 23, 2023 (3d) |
| Oct 3, 2023 | ALVR | ↓ Sell | 755 | $1.98 | $1K | Direct | Oct 5, 2023 (2d) |
| Aug 17, 2023 | ALVR | ↓ Sell | 10,516 | $2.50 | $26K | Direct | Aug 21, 2023 (4d) |
| Jul 20, 2023 | ALVR | ↓ Sell | 2,635 | $3.44 | $9K | Direct | Jul 21, 2023 (1d) |
| Jul 5, 2023 | ALVR | ↓ Sell | 2,983 | $3.05 | $9K | Direct | Jul 6, 2023 (1d) |
| Apr 20, 2023 | ALVR | ↓ Sell | 2,683 | $3.66 | $10K | Direct | Apr 21, 2023 (1d) |
| Jan 20, 2023 | ALVR | ↓ Sell | 6,537 | $5.09 | $33K | Direct | Jan 23, 2023 (3d) |
| Oct 19, 2022 | ALVR | ↓ Sell | 1,449 | $9.36 | $14K | Direct | Oct 24, 2022 (5d) |
| Jul 20, 2022 | ALVR | ↓ Sell | 1,432 | $5.21 | $7K | Direct | Jul 21, 2022 (1d) |
| Apr 20, 2022 | ALVR | ↓ Sell | 1,162 | $6.68 | $8K | Direct | Apr 22, 2022 (2d) |
| Jan 20, 2022 | ALVR | ↓ Sell | 6,450 | $8.75 | $56K | Direct | Jan 24, 2022 (4d) |
| May 4, 2021 | VRNA | ↓ Sell | 10,016 | $0.84 | $8K | Direct | May 5, 2021 (1d) |
| Feb 1, 2021 | VRNA | ↓ Sell | 10,224 | $0.99 | $10K | Direct | Feb 3, 2021 (2d) |
| Aug 8, 2016 | ALXN | ↓ Sell | 277 | $137.14 | $38K | Direct | Aug 10, 2016 (2d) |
| Feb 29, 2016 | ALXN | ↓ Sell | 1,122 | $138.91 | $156K | Direct | Mar 1, 2016 (1d) |
| Feb 8, 2016 | ALXN | ↓ Sell | 6,547 | $140.04 | $917K | Direct | Feb 8, 2016 (0d) |
| Aug 4, 2015 | ALXN | ↓ Sell | 675 | $196.52 | $133K | Direct | Aug 5, 2015 (1d) |
| Mar 2, 2015 | ALXN | ↓ Sell | 487 | $180.34 | $88K | Direct | Mar 3, 2015 (1d) |
| Feb 10, 2015 | ALXN | ↓ Sell | 1,985 | $171.15 | $340K | Direct | Feb 12, 2015 (2d) |
| Feb 9, 2015 | ALXN | ↓ Sell | 2,703 | $174.18 | $471K | Direct | Feb 9, 2015 (0d) |
| Feb 4, 2015 | ALXN | ↓ Sell | 1,571 | $174.19 | $274K | Direct | Feb 5, 2015 (1d) |
| Dec 18, 2014 | ALXN | ↓ Sell10b5-1 | 5,493 | $182.08 | $1.0M | Direct | Dec 19, 2014 (1d) |
| Dec 3, 2014 | ALXN | ↓ Sell10b5-1 | 75,000 | $198.96 | $14.9M | Direct | Dec 4, 2014 (1d) |
| Nov 6, 2014 | ALXN | ↓ Sell10b5-1 | 5,693 | $195.00 | $1.1M | Direct | Nov 10, 2014 (4d) |
| Nov 3, 2014 | ALXN | ↓ Sell10b5-1 | 49,307 | $192.63 | $9.5M | Direct | Nov 4, 2014 (1d) |
| Aug 4, 2014 | ALXN | ↓ Sell | 1,525 | $157.82 | $241K | Direct | Aug 5, 2014 (1d) |
| Feb 7, 2014 | ALXN | ↓ Sell | 1,620 | $155.57 | $252K | Direct | Feb 10, 2014 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Vikas Sinha's insider trades
Vikas Sinha is a director at Verona Pharma (VRNA). Since Sep 24, 2007, Vikas has reported no open-market purchases and 97 sales worth $81.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
21 sales (82% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (33 filings), option exercises (28 filings), other transactions (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.